Sanjay Kumar Jain

Sanjay Kumar Jain

Active Director Director DIN 01159627
DIN 01159627 First appointment Sep 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Sep 2004
Shareholding value •••• Premium profile

About Sanjay Kumar Jain

Data last updated:

Sanjay Kumar Jain is a Director at Cosmas Research Lab Limited (since 2008), Whole-Time Director at Cosmas Pharmacls Limited (since 2010) and Director at Cruise Pharmacia Private Limited (since 2007), and holds 1 more current directorship. The companies operate in Pharma and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹119 Cr; the largest is Cosmas Research Lab Limited at ₹93.42 Cr (FY 2025). Earlier, Sanjay Kumar Jain was a Director at Kelter Care Pharma Private Limited (2015–2019) and Director at Cosmas Medical Studies Private Limited (from 2010).

DIN 01159627
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2004
Oldest Company Age 23 yrs
Largest company Cosmas Research Lab Limited · ₹93.42 Cr (FY 2025)
Combined revenue ₹119 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cosmas Research Lab Limited U24110PB2008PLC031925
Director14 May 20082008₹93.42 Cr (FY 2025)Active
Cosmas Pharmacls Limited U24232PB2010PLC033534
Whole-Time Director22 Jan 20102010₹23.95 Cr (FY 2025)Active
Cruise Pharmacia Private Limited U52310PB2007PTC031411
Director11 Oct 20072007₹1.75 Cr (FY 2025)Active
Armour Remedies India Limited U24232PB2003PLC026045
Director30 Sep 20042003Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kelter Care Pharma Private Limited U24232PB2015PTC039463
Director18 May 20152015₹70.2 Lakh (FY 2022)Active
Director08 Jul 20102010₹8.1 Lakh (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cosmas Research Lab Limited
Armour Remedies India Limited
Cosmas Pharmacls Limited
Cruise Pharmacia Private Limited
Premium access

Shareholding and investment profile for Sanjay Kumar Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kumar Jain

Sanjay Kumar Jain currently holds 4 directorships: Cosmas Research Lab Limited (Director, since 14 May 2008, revenue ₹93.42 Cr (FY 2025)); Cosmas Pharmacls Limited (Whole-Time Director, since 22 Jan 2010, revenue ₹23.95 Cr (FY 2025)); Cruise Pharmacia Private Limited (Director, since 11 Oct 2007, revenue ₹1.75 Cr (FY 2025)); Armour Remedies India Limited (Director, since 30 Sep 2004).

Sanjay Kumar Jain was first appointed on 30 Sep 2004 as Director at Armour Remedies India Limited. The most recent appointment on record is 18 May 2015 at Kelter Care Pharma Private Limited.

The 3 current companies of Sanjay Kumar Jain that report revenue have a combined latest revenue of ₹119 Cr: Cosmas Research Lab Limited ₹93.42 Cr (FY 2025); Cosmas Pharmacls Limited ₹23.95 Cr (FY 2025); Cruise Pharmacia Private Limited ₹1.75 Cr (FY 2025).

Sanjay Kumar Jain held 2 earlier board appointments: Kelter Care Pharma Private Limited (Director, 18 May 2015 to 21 Jan 2019); Cosmas Medical Studies Private Limited (Director, from 08 Jul 2010).

The current boards of Sanjay Kumar Jain's companies include Manu Jain (Cosmas Research Lab Limited), Punit Jain (Cosmas Research Lab Limited), Tanuj Kumar Jain (Cosmas Research Lab Limited), Tanuj Kumar Jain (Cosmas Research Lab Limited), Kuldip Singh (Cosmas Pharmacls Limited), Parkash Chopra (Cosmas Pharmacls Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available